how to get glp-1 agonists Understanding GLP-1 and Anesthesia: Considerations and
Description
Given that atherosclerotic cardiovascular disease and CKD are the leading causes of morbidity and mortality in type 1 diabetes [24], it is reassuring that we show that SGLT2i therapy also confers similar benefits in type 1 diabetes
Rosenstock J, Perkovic V, Johansen OE et al (2019) Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial
infantis supplementation improved symptoms in irritable bowel syndrome patients and reduced inflammatory markers
Lipscombe L, Booth G, Butalia S, et al
Utilizing receptorligand interactions from molecular docking, a pharmacophore model was developed to understand the binding patterns of structurally diverse compounds at the receptor's active site
